Ventyx’s $174 Million IPO

Wilson Sonsini Goodrich & Rosati advised Ventyx on the deal.Ventyx Biosciences, a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here